These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 9234808

  • 21. Human CD4+ T cells induced by synthetic peptide malaria vaccine are comparable to cells elicited by attenuated Plasmodium falciparum sporozoites.
    Calvo-Calle JM, Oliveira GA, Nardin EH.
    J Immunol; 2005 Dec 01; 175(11):7575-85. PubMed ID: 16301667
    [Abstract] [Full Text] [Related]

  • 22. Epitope mapping of PfCP-2.9, an asexual blood-stage vaccine candidate of Plasmodium falciparum.
    Li C, Wang R, Wu Y, Zhang D, He Z, Pan W.
    Malar J; 2010 Apr 12; 9():94. PubMed ID: 20384992
    [Abstract] [Full Text] [Related]

  • 23. The Plasmodium falciparum Cell-Traversal Protein for Ookinetes and Sporozoites as a Candidate for Preerythrocytic and Transmission-Blocking Vaccines.
    Espinosa DA, Vega-Rodriguez J, Flores-Garcia Y, Noe AR, Muñoz C, Coleman R, Bruck T, Haney K, Stevens A, Retallack D, Allen J, Vedvick TS, Fox CB, Reed SG, Howard RF, Salman AM, Janse CJ, Khan SM, Zavala F, Gutierrez GM.
    Infect Immun; 2017 Feb 12; 85(2):. PubMed ID: 27895131
    [Abstract] [Full Text] [Related]

  • 24. Immunogenicity of Plasmodium falciparum and Plasmodium vivax circumsporozoite protein repeat multiple antigen constructs (MAC).
    Udhayakumar V, Saekhou A, Fang S, Jue D, Wohlhueter RM, Lal AA.
    Vaccine; 1998 Feb 12; 16(9-10):982-8. PubMed ID: 9682348
    [Abstract] [Full Text] [Related]

  • 25. Characterization of immunoglobulin G antibodies to Plasmodium falciparum sporozoite surface antigen MB2 in malaria exposed individuals.
    Nguyen TV, Sacci JB, de la Vega P, John CC, James AA, Kang AS.
    Malar J; 2009 Oct 23; 8():235. PubMed ID: 19852802
    [Abstract] [Full Text] [Related]

  • 26. A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge.
    Calvo-Calle JM, Oliveira GA, Watta CO, Soverow J, Parra-Lopez C, Nardin EH.
    Infect Immun; 2006 Dec 23; 74(12):6929-39. PubMed ID: 17030584
    [Abstract] [Full Text] [Related]

  • 27. Monoclonal antibodies of three different immunoglobulin G isotypes produced by immunization with a synthetic peptide or native protein protect mice against challenge with Plasmodium yoelii sporozoites.
    Ak M, Bower JH, Hoffman SL, Sedegah M, Lees A, Carter M, Beaudoin RL, Charoenvit Y.
    Infect Immun; 1993 Jun 23; 61(6):2493-7. PubMed ID: 8500885
    [Abstract] [Full Text] [Related]

  • 28. Induction of protective immune responses by immunization with linear multiepitope peptides based on conserved sequences from Plasmodium falciparum antigens.
    Bharadwaj A, Sharma P, Joshi SK, Singh B, Chauhan VS.
    Infect Immun; 1998 Jul 23; 66(7):3232-41. PubMed ID: 9632590
    [Abstract] [Full Text] [Related]

  • 29. Antibodies against thrombospondin-related anonymous protein do not inhibit Plasmodium sporozoite infectivity in vivo.
    Gantt S, Persson C, Rose K, Birkett AJ, Abagyan R, Nussenzweig V.
    Infect Immun; 2000 Jun 23; 68(6):3667-73. PubMed ID: 10816526
    [Abstract] [Full Text] [Related]

  • 30. Plasmodium falciparum sporozoite immunization protects against Plasmodium berghei sporozoite infection.
    Sina BJ, do Rosario VE, Woollett G, Sakhuja K, Hollingdale MR.
    Exp Parasitol; 1993 Sep 23; 77(2):129-35. PubMed ID: 8375482
    [Abstract] [Full Text] [Related]

  • 31. Proteolytic Cleavage of the Plasmodium falciparum Circumsporozoite Protein Is a Target of Protective Antibodies.
    Espinosa DA, Gutierrez GM, Rojas-López M, Noe AR, Shi L, Tse SW, Sinnis P, Zavala F.
    J Infect Dis; 2015 Oct 01; 212(7):1111-9. PubMed ID: 25762791
    [Abstract] [Full Text] [Related]

  • 32. In vitro and in vivo inhibition of malaria parasite infection by monoclonal antibodies against Plasmodium falciparum circumsporozoite protein (CSP).
    Livingstone MC, Bitzer AA, Giri A, Luo K, Sankhala RS, Choe M, Zou X, Dennison SM, Li Y, Washington W, Ngauy V, Tomaras GD, Joyce MG, Batchelor AH, Dutta S.
    Sci Rep; 2021 Mar 05; 11(1):5318. PubMed ID: 33674699
    [Abstract] [Full Text] [Related]

  • 33. Immunogenicity and in vitro protective efficacy of a recombinant multistage Plasmodium falciparum candidate vaccine.
    Shi YP, Hasnain SE, Sacci JB, Holloway BP, Fujioka H, Kumar N, Wohlhueter R, Hoffman SL, Collins WE, Lal AA.
    Proc Natl Acad Sci U S A; 1999 Feb 16; 96(4):1615-20. PubMed ID: 9990073
    [Abstract] [Full Text] [Related]

  • 34. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
    Dobaño C, Doolan DL.
    Mol Immunol; 2007 Apr 16; 44(11):3037-48. PubMed ID: 17303242
    [Abstract] [Full Text] [Related]

  • 35. Immunization of Malaria-Preexposed Volunteers With PfSPZ Vaccine Elicits Long-Lived IgM Invasion-Inhibitory and Complement-Fixing Antibodies.
    Zenklusen I, Jongo S, Abdulla S, Ramadhani K, Lee Sim BK, Cardamone H, Flannery EL, Nguyen T, Fishbaugher M, Steel RWJ, Betz W, Carmago N, Mikolajczak S, Kappe SHI, Hoffman SL, Sack BK, Daubenberger C.
    J Infect Dis; 2018 Apr 23; 217(10):1569-1578. PubMed ID: 29438525
    [Abstract] [Full Text] [Related]

  • 36. Immunogenicity of well-characterized synthetic Plasmodium falciparum multiple antigen peptide conjugates.
    Joshi MB, Gam AA, Boykins RA, Kumar S, Sacci J, Hoffman SL, Nakhasi HL, Kenney RT.
    Infect Immun; 2001 Aug 23; 69(8):4884-90. PubMed ID: 11447164
    [Abstract] [Full Text] [Related]

  • 37. A highly infectious Plasmodium yoelii parasite, bearing Plasmodium falciparum circumsporozoite protein.
    Zhang M, Kaneko I, Tsao T, Mitchell R, Nardin EH, Iwanaga S, Yuda M, Tsuji M.
    Malar J; 2016 Apr 12; 15():201. PubMed ID: 27068454
    [Abstract] [Full Text] [Related]

  • 38. Generation of Plasmodium falciparum parasite-inhibitory antibodies by immunization with recombinantly-expressed CyRPA.
    Favuzza P, Blaser S, Dreyer AM, Riccio G, Tamborrini M, Thoma R, Matile H, Pluschke G.
    Malar J; 2016 Mar 15; 15():161. PubMed ID: 26979066
    [Abstract] [Full Text] [Related]

  • 39. P. falciparum and P. vivax Epitope-Focused VLPs Elicit Sterile Immunity to Blood Stage Infections.
    Whitacre DC, Espinosa DA, Peters CJ, Jones JE, Tucker AE, Peterson DL, Zavala FP, Milich DR.
    PLoS One; 2015 Mar 15; 10(5):e0124856. PubMed ID: 25933001
    [Abstract] [Full Text] [Related]

  • 40. Current Challenges in the Identification of Pre-Erythrocytic Malaria Vaccine Candidate Antigens.
    Bettencourt P.
    Front Immunol; 2020 Mar 15; 11():190. PubMed ID: 32153565
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.